205
Views
7
CrossRef citations to date
0
Altmetric
Review

Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma

ORCID Icon &
Pages 775-783 | Published online: 24 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kiarash Saleki, Mohamad Hosein Mohamadi, Parsa Alijanizadeh & Nima Rezaei. (2023) Neurological adverse effects of chimeric antigen receptor T-cell therapy. Expert Review of Clinical Immunology 19:11, pages 1361-1383.
Read now

Articles from other publishers (6)

Jason R. Westin, Frederick L. Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David B. Miklos, Matthew L. Ulrickson, Miguel-Angel Perales, Umar Farooq, Luciano Wannesson, Lori Leslie, Marie José Kersten, Caron A. Jacobson, John M. Pagel, Gerald Wulf, Patrick Johnston, Aaron P. Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia T. Snider, Paul Cheng, Christina To, Olalekan O. Oluwole & Anna Sureda. (2023) Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clinical Cancer Research 29:10, pages 1894-1905.
Crossref
Shannon P. Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal & Maciej M. Mrugala. (2022) Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current Treatment Options in Oncology 23:12, pages 1845-1860.
Crossref
Yanping Li, Yue Ming, Ruoqiu Fu, Chen Li, Yuanlin Wu, Tingting Jiang, Ziwei Li, Rui Ni, Li Li, Hui Su & Yao Liu. (2022) The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions. Frontiers in Pharmacology 13.
Crossref
Robert C. Sterner & Rosalie M. Sterner. (2022) Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy. Frontiers in Immunology 13.
Crossref
Barry Paul, Cesar Rodriguez & Saad Z. Usmani. (2022) BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy. Drugs 82:6, pages 613-631.
Crossref
Poonam R. Pandey, Ken H. Young, Dhiraj Kumar & Neeraj Jain. (2022) RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics. Molecular Cancer 21:1.
Crossref